These effects, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the concept of focusing on ACKR3 as a unique strategy to modulate the opioid technique, which could open new therapeutic avenues for opioid-linked disorders. “Over-all, the discovery in the https://davidb050rja6.gigswiki.com/user